Barbara Ann Karmanos Cancer Institute

09/21/2026 | Press release | Archived content

IN THE NEWS: What is Myelodysplastic Syndrome

September 21, 2026

Patient Power

Jay Yang, M.D., hematologist, medical oncologist and leader of the Hematology Oncology Multidisciplinary Team at Karmanos, explained to Patient Power that myelodysplastic syndrome, or MDS, 'is a cancer of the blood-forming cells (hematopoietic stem cells).' He further goes over the risk factors and symptoms of this rare disease.

Read the article here.

Barbara Ann Karmanos Cancer Institute published this content on September 21, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 28, 2026 at 17:43 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]